Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionIntegrated Wealth Concepts LLC
Latest Disclosed Ownership4,201 shares
Latest Disclosed Value $ 3,246,138
Integrated Wealth Concepts LLC reports 112.60% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On May 15, 2026 - Integrated Wealth Concepts LLC filed a 13F-HR form disclosing ownership of 4,201 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $3,246,138 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,976 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 112.60% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 4,201 2,225 112.60 3,246 112.85 0.0259
2026-02-13 2025-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 1,976 545 38.09 1,525 89.68 0.0181
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 1,431 1,431 805 0.0072
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 0 -752 -100.00 0 -100.00
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 752 -411 -35.34 477 -42.51 0.0056
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 1,163 415 55.48 828 5.34 0.0096
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 748 214 40.07 786 40.11 0.0096
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 534 30 5.95 561 15.67 0.0077
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 504 102 25.37 485 37.39 0.0070
2024-02-13 2023-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 402 -55 -12.04 353 -6.12 0.0058
2023-11-15 2023-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 457 -36 -7.30 376 6.21 0.0066
2023-08-15 2023-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 493 5 1.02 354 0.0061
2023-05-03 2023-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 488 142 41.04 0 0.0083
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 346 -176 -33.72 0 -100.00 0.0068
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 522 -518 -49.81 360 -41.46 0.0115
2022-08-08 2022-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 1,040 492 89.78 615 60.57 0.0191
2022-05-12 2022-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 548 -16 -2.84 383 7.58 0.0117
2022-02-15 2021-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 564 19 3.49 356 7.88 0.0106
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 545 118 27.63 330 38.66 0.0107
2021-08-13 2021-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 427 427 238 0.0084
2021-05-13 2021-03-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 0 -546 -100.00 0 -100.00
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 546 65 13.51 264 -1.86 0.0125
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 481 28 6.18 269 -4.95 0.0166
2020-07-30 2020-06-30 13F REGENERON PHARMACEUTICAL Common Stock 75886F107 453 453 283 0.0204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.